Member Info for ShearClass

Yep, super slow this week across the board this week it seems! Almost all buys as you say, which is positive as it suggests the RNS last week didn't attract any short termers. Look forward to the next news here.

Bargain? Why would you buy before they raise? The 41% fall is due to the financial peril they find themselves in, nothing to do with supply and demand for shares.

Been watching the slow motion car crash for some time, seems like there was a complete refusal to accept that funds needed to be raised? A raise at 40p looks mightily attractive right now, why on earth have they left it so late? You simply cannot rely on external grant funding if the risk of failure is delaying product development. Crazily bad financial management.

Re. US Sales, if we were getting a royalty via from OEM then this would be recorded third party income rather than sales... would be a delightful surprise in the half year report if we had £10m + of royalty income...

I agree with it not being shared when it's being shorted etc, the bigger the element of surprise the better. Mess the shorters up rather than give them a chance to escape!

Agree Adastra, it's got all the hallmarks of a midcap of the future if they can execute. And if they can continue the recent momentum the share price should appreciate considerably, certainly in risk/reward terms it's got to be one of the best on AIM...

@Ponkey, I've been watching Paris for ages as I'm sure you have too. I've come to the conclusion that the order book data may be 15 mins delayed? It rarely if ever ties up with the share price movements. Back to €2.705 though, so not flying but a recovery of sorts. Hopefully head towards €3 into close...

Can you imagine if they had developed a rapid POC test, antibody test & upgraded PCR in combination with AZN / GSK? Then you'd be talking about £10 per share! Ha. We can dream.

This BGF convertible will be the next to get converted IMO. Conversion price of 28.5p which means they'll get around 9m shares.

"Business Growth Fund (BGF)

The Company entered into an agreement with the Business Growth Fund (BGF) that became effective on 10 December 2018. Under the terms of the agreement BGF and the Company entered into a convertible loan arrangement. The main terms of the convertible loan note are:

-- GBP2.5m loan that matures on 30 June 2025.
-- Interest accrues on the loan at a rate of 7%, payable quarterly.
-- Interest can be deferred into the principal up until 31 December 2021 and then needs to be paid in full.

-- The loan converts at 28.75p which was 125% of the share price on 10 December.
-- Certain warranties have been granted by the Company and the Executive Directors to BGF and BGF consent is required on certain matters.

-- The loan came conditional with a GBP1m subscription to the December 2018 fund-raising process.

-- The maximum number of shares to be issued to BGF on conversion of the loan notes, when aggregated with the ordinary shares held by BGF and persons acting in concert with BGF, is capped at 29.9% of the issued share capital of the Company."

And the more units they sell this year, the more genesig products they'll sell in following years - a really nice halo effect should occur.

Alan sugar you don't half spout some crap, give me sharehunter 24/7 over your bleating.

"Due diligence is not worth a whole late when over 50% of the market cap can be wiped off in a month without any disastrous news."

Of course due diligence is worth it, as it means that you can hold through a 50% fall & add to your holding, rather than selling at the lows like LogicMoz yesterday. Research = confidence, unless the story changes.

Yep I’m with morningsun, your posts are more annoying, nothing wrong with some enthusiasm / positivity to offset the frustrating share price!

My goodness, France is green... long may it continue, we have a lot of recovering to do!

A 10 minute test would absolutely be a game changer, the huge question is why hasn’t anyone else achieved it yet given we are 6 months into the virus?

If it was as simple as slippery AS suggested in April / May, why has nobody else nailed it yet? Remember the 5 minute Abbott test? Clearly there are huge challenges in achieving high enough sensitivity.

I’ll believe it when I see it, and buy on the RNS rather than gamble with a company where the management have proved themselves to be untrustworthy time and time again.

Very smart decision, you already held though didn't you? If I'd been aware of the potential at that time I'd have loaded up, you'll never see anything close to those prices again IMO. Smashing finish today, wonder if that rise was caused by Doc buying in? Or is he waiting for the company to come back on whether their patents are any good... LOL.

The £60k buy from the chairman wasn't piddly, especially as it more than doubled his holding...

Yep, saw that earlier, thanks Don. £5 paid for the first time, very strong day following on from Friday. Definite US buying interest in the afternoons...

@themuir, it honestly wouldn't surprise me, they've got their £48m - why would they have raised so much if the test was going to be a world beater?

Wow, someone is dumping big time today, any price will do. Wonder why?!

@Matt, thanks for the update. Worth putting into context that at production of 10m tests per month, and 96 tests per kit, they are producing 3472 kits per day, so it's hardly surprising that they have some stock available. Indeed the whole purpose in scaling up production was to be able to meet demand - no good having demand if you can't service it.